Chemotherapy of non‐small cell lung cancer: Clinical trials at the Memorial Sloan‐Kettering Cancer Center
Richard J. Gralla(Jacobi Medical Center), Robert B. Golbey(Memorial Sloan Kettering Cancer Center), Esteban Cvitkovic(Inserm), David P. Kelsen(Memorial Sloan Kettering Cancer Center), E. S. Casper(Memorial Sloan Kettering Cancer Center), Gordon B. Magill(Memorial Sloan Kettering Cancer Center), R. Wittes(National Institutes of Health), Susan E. Krown(Memorial Sloan Kettering Cancer Center)
Cited by 5
Related Papers
Cetuximab Shows Activity in Colorectal Cancer Patients With Tumors That Do Not Express the Epidermal Growth Factor Receptor by Immunohistochemistry
|Journal of Clinical Oncology|2005|1.1k
Topotecan Versus Cyclophosphamide, Doxorubicin, and Vincristine for the Treatment of Recurrent Small-Cell Lung Cancer
|Journal of Clinical Oncology|1999|960
Kaposi sarcoma
|Nature Reviews Disease Primers|2019|707
Recommendations for the Use of Antiemetics: Evidence-Based, Clinical Practice Guidelines
|Journal of Clinical Oncology|1999|670
A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer
|Annals of Oncology|1996|569